Printer friendly version Share

News Release

Patients with aberrations in two genes respond better to drugs blocking a well-known cancer pathway

06 November 2012 The European CanCer Organisation (ECCO)

Please login or register to view articles older than 3 months

Cambridge blue millet expertsvar 2015 Elhuyar with Basque eNEWS6 Facebook 2015 FNSF ad New Norwegian logo